Weekly Recap

CBD Effective Regardless of Infantile Spasm History, Fenfluramine Effective in CDD, Wristband Sensor Data May Predict Seizures

ByNeurologyLive® Staff

December 12th 2020

Neurology News Network for the week ending December 12, 2020.

Smartphone PMR Treats Migraine, NMOSD Relapse in Pregnant Women, FDA Grants ALS Agent Orphan Drug Designation

ByNeurologyLive® Staff

December 5th 2020

Neurology News Network for the week ending December 5, 2020.

NDA For INP104 Submitted, Sodium Oxybate Improves Nocturnal RBD, Health-Deficit Accumulation Leads to Cognitive Impairment

ByNeurologyLive® Staff

November 28th 2020

Neurology News Network for the week ending November 28, 2020.

Early Life Working Impacts Cognitive Decline, Cleveland Clinic Awarded NIH Grant, Earlier Treatment More Effective in Parkinson Disease

ByNeurologyLive® Staff

November 21st 2020

Neurology News Network for the week ending November 21, 2020.

Aducanumab Not Recommended by FDA, White Paper on Mechanical Thrombectomy, Status Epilepticus Treatment FDA Approved

ByNeurologyLive® Staff

November 14th 2020

Neurology News Network for the week ending November 14, 2020.

PD GENEration Receives Additional Funding, Continuous Ocrelizumab Effective in Progressive MS, Guidelines for Down Syndrome Published

ByNeurologyLive® Staff

November 7th 2020

Neurology News Network for the week ending November 7, 2020.

Diazepam Granted Fast Track, Nerivio Receives FDA Clearance, Zolmitriptan Gets CRL Following NDA Submission

ByNeurologyLive® Staff

October 31st 2020

Neurology News Network for the week ending October 31, 2020.

JZP-258 Effective to Treat Narcolepsy, Pavel Klein Discusses Telemedicine Limitations, Earlier Focal Epilepsy Diagnosis Shows Benefit

ByNeurologyLive® Staff

October 24th 2020

Neurology News Network for the week ending October 24, 2020.

sNDA Accepted For Rimegepant, FDA Expands Pitolisant Indication, Givinostat Wins Rare Pediatric Disease Designation

ByNeurologyLive® Staff

October 17th 2020

Neurology News Network for the week ending October 17, 2020.

Zolgensma Shows Therapeutic Benefit, Anticholinergic Medications Increase MCI Risk, FDA Issues DRL For Zolmitriptan

ByNeurologyLive® Staff

October 10th 2020

Neurology News Network for the week ending October 10, 2020.

FDA Sends CRL For Diazepam, Insomnia Linked to Cognitive Impairment, Midazolam Underutilized By EMS

ByNeurologyLive® Staff

October 3rd 2020

Neurology News Network for the week ending October 2, 2020.

Sumifilam Improves Alzheimer Biomarkers, Fenfluramine Phase 3 Results, Ozanimod Lowers ARR

ByNeurologyLive® Staff

September 26th 2020

Neurology News Network for the week ending September 26, 2020.

Opicapone Treats Motor Fluctuations, Directional DBS Favored in PD, MRgFUS is Effective as Hand Tremor Treatment

ByNeurologyLive® Staff

September 19th 2020

Neurology News Network for the week ending September 19, 2020.

Pocket Card Treats Status Epilepticus, Pitolisant Shows No Cardiac Signals, SSRIs Associated With Increased Risk of Recurrent Stroke

ByNeurologyLive® Staff

September 12th 2020

Neurology News Network for the week ending September 12, 2020.

Lacosamide Meets Primary End Point, Lemborexant Well-Tolerated in Elders, Cala Trio Reduces Hand Tremor

ByNeurologyLive® Staff

September 5th 2020

Neurology News Network for the week ending September 5, 2020.

MS Physical Activity Recommendations, FDA Approves Celecoxib, Rituximab Effect on Myasthenia Gravis

ByNeurologyLive® Staff

May 9th 2020

Neurology News Network for the week ending May 9, 2020.

Risdiplam Meets End Point, Fenfluramine Effective in Treating Dravet Syndrome, Rimegepant Sees Early Results in Migraine

ByNeurologyLive® Staff

May 2nd 2020

Neurology News Network for the week ending May 2.

Daridorexant Improves Daytime Sleepiness, Vutrisiran Gains Fast Track Designation, Erenumab Effective in Migraine

ByNeurologyLive® Staff

April 25th 2020

Neurology News Network for the week ending April 25, 2020.

Neurologic Symtpoms of COVID19, Rimegepant Available Via Telemedicine, Natalizumab

ByNeurologyLive® Staff

April 18th 2020

Neurology News Network for the week ending April 18, 2020.

Risdiplam PDUFA Pushed Back, Masitinib Gains NDA, COVID19 Affects CNS

ByNeurologyLive® Staff

April 11th 2020

Neurology News Network for the week ending April 11, 2020.

CBD Under FDA Review, Rimegepant Meets Endpoint, Sleep-Disordered Breathing Associated With Alzheimer Disease

ByNeurologyLive® Staff

April 4th 2020

Neurology News Network for the week ending April 4, 2020.

Teleheath Webinar on COVID-19 Now Available, Coronavirus' Effect on MS Patients, New Mind Moments Podcast

ByNeurologyLive® Staff

March 21st 2020

Neurology News Network for the week ending March 21, 2020.

Cenobamate Gets Schedule V Designation, ICER Publishes Migraine Treatment Review, FDA Approves RNS System Labeling Update

ByNeurologyLive® Staff

March 14th 2020

Neurology News Network for the week ending March 14, 2020.

FDA Approves Rimegepant, Results on Ofatumumab Trial, Diazepam Becomes Commercially Available

ByNeurologyLive® Staff

March 7th 2020

Neurology News Network for the week ending March 7, 2020.

Augusto Miravalle, MD: How Cladribine Sets Itself Apart in MS

ByAugusto Miravalle, MD

March 6th 2020

The associate professor in the department of neurology at the University of Colorado and neurologist at Advanced Neurology of Colorado discussed the advantages of cladribine and details of the ongoing CLICK-MS study.

Huntington Disease Trial Results; Mind Moments Podcast Now Live; PMM Trial Falls Short

ByNeurologyLive® Staff

January 4th 2020

Neurology News Network for the week ending January 4, 2020.

CBD Reduces Seizures in Tuberous Sclerosis Complex, Fenfluramine Reduces Seizure Frequency While Improving Executive Function, Intranasal Diazepam Effective to Treat Seizures Regardless of Usage Frequency

ByNeurologyLive® Staff

December 14th 2019

Neurology News Network for the week ending December 14, 2019.

Risdiplam Shows Positive Results in SMA, Study Trials for DMD Discontinued, Neflamapimod Granted Fast Track for Treatment of Dementia with Lewy Bodies

ByNeurologyLive® Staff

November 16th 2019

Neurology News Network for the week ending November 16, 2019.

Aducanumab Reversal Sends Drug to FDA, Cala Trio Reduces Hand Tremor, Ganaxolone Promising in Refractory Status Epilepticus

ByNeurologyLive® Staff

October 26th 2019

Neurology News Network for the week ending October 26, 2019.

Lasmiditan Approved for Acute Migraine, Istradefylline Now Available for Parkinson Off Episodes, Omaveloxolone Promising in Friedreich's Ataxia

ByNeurologyLive® Staff

October 19th 2019

Neurology News Network for the week ending October 19, 2019.

Weekly Recap

CBD Effective Regardless of Infantile Spasm History, Fenfluramine Effective in CDD, Wristband Sensor Data May Predict Seizures

Smartphone PMR Treats Migraine, NMOSD Relapse in Pregnant Women, FDA Grants ALS Agent Orphan Drug Designation

NDA For INP104 Submitted, Sodium Oxybate Improves Nocturnal RBD, Health-Deficit Accumulation Leads to Cognitive Impairment

Early Life Working Impacts Cognitive Decline, Cleveland Clinic Awarded NIH Grant, Earlier Treatment More Effective in Parkinson Disease

Aducanumab Not Recommended by FDA, White Paper on Mechanical Thrombectomy, Status Epilepticus Treatment FDA Approved

PD GENEration Receives Additional Funding, Continuous Ocrelizumab Effective in Progressive MS, Guidelines for Down Syndrome Published

Diazepam Granted Fast Track, Nerivio Receives FDA Clearance, Zolmitriptan Gets CRL Following NDA Submission

JZP-258 Effective to Treat Narcolepsy, Pavel Klein Discusses Telemedicine Limitations, Earlier Focal Epilepsy Diagnosis Shows Benefit

sNDA Accepted For Rimegepant, FDA Expands Pitolisant Indication, Givinostat Wins Rare Pediatric Disease Designation

Zolgensma Shows Therapeutic Benefit, Anticholinergic Medications Increase MCI Risk, FDA Issues DRL For Zolmitriptan

FDA Sends CRL For Diazepam, Insomnia Linked to Cognitive Impairment, Midazolam Underutilized By EMS

Sumifilam Improves Alzheimer Biomarkers, Fenfluramine Phase 3 Results, Ozanimod Lowers ARR

Opicapone Treats Motor Fluctuations, Directional DBS Favored in PD, MRgFUS is Effective as Hand Tremor Treatment

Pocket Card Treats Status Epilepticus, Pitolisant Shows No Cardiac Signals, SSRIs Associated With Increased Risk of Recurrent Stroke

Lacosamide Meets Primary End Point, Lemborexant Well-Tolerated in Elders, Cala Trio Reduces Hand Tremor

MS Physical Activity Recommendations, FDA Approves Celecoxib, Rituximab Effect on Myasthenia Gravis

Risdiplam Meets End Point, Fenfluramine Effective in Treating Dravet Syndrome, Rimegepant Sees Early Results in Migraine

Daridorexant Improves Daytime Sleepiness, Vutrisiran Gains Fast Track Designation, Erenumab Effective in Migraine

Neurologic Symtpoms of COVID19, Rimegepant Available Via Telemedicine, Natalizumab

Risdiplam PDUFA Pushed Back, Masitinib Gains NDA, COVID19 Affects CNS

CBD Under FDA Review, Rimegepant Meets Endpoint, Sleep-Disordered Breathing Associated With Alzheimer Disease

Teleheath Webinar on COVID-19 Now Available, Coronavirus' Effect on MS Patients, New Mind Moments Podcast

Cenobamate Gets Schedule V Designation, ICER Publishes Migraine Treatment Review, FDA Approves RNS System Labeling Update

FDA Approves Rimegepant, Results on Ofatumumab Trial, Diazepam Becomes Commercially Available

Augusto Miravalle, MD: How Cladribine Sets Itself Apart in MS

Huntington Disease Trial Results; Mind Moments Podcast Now Live; PMM Trial Falls Short

CBD Reduces Seizures in Tuberous Sclerosis Complex, Fenfluramine Reduces Seizure Frequency While Improving Executive Function, Intranasal Diazepam Effective to Treat Seizures Regardless of Usage Frequency

Risdiplam Shows Positive Results in SMA, Study Trials for DMD Discontinued, Neflamapimod Granted Fast Track for Treatment of Dementia with Lewy Bodies

Aducanumab Reversal Sends Drug to FDA, Cala Trio Reduces Hand Tremor, Ganaxolone Promising in Refractory Status Epilepticus

Lasmiditan Approved for Acute Migraine, Istradefylline Now Available for Parkinson Off Episodes, Omaveloxolone Promising in Friedreich's Ataxia

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

Understanding Ocrelizumab’s Impact on Advanced Progressive MS: Insights From Dr. Gavin Giovannoni

How Multiple Sclerosis Affects Men

Trofinetide Leads to Real-World Improvements in Rett Syndrome Symptoms, LOTUS Study Finds

Key Highlights from the 2025 American Neurological Association Annual Meeting

Reflecting on Contributions to Child Neurology at 2025 CNS Annual Meeting: Brenda Banwell, MD, FRCPC, FAAN